Literature DB >> 11961269

Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule.

Emi Tsuchiya1, Kanetsu Sugawara1, Seiji Hongo1, Yoko Matsuzaki1, Yasushi Muraki1, Zhu-Nan Li1, Kiyoto Nakamura1.   

Abstract

The haemagglutinin (HA) of influenza A/H2N2 virus possesses six antigenic sites (I-A to I-D, II-A and II-B), and sites I-A, I-B and I-C are located in the regions corresponding to sites A, B and D on the H3 HA. We demonstrated previously that most escape mutants selected by mAbs to site I-A, I-B or I-C had acquired a new oligosaccharide at position 160, 187 or 131, respectively, but this has never occurred during circulation of A/H2N2 virus in humans. Here, to examine whether the H2 HA has the potential to gain two new oligosaccharides on its tip, 31 double escape mutants were isolated by using a single escape mutant with an oligosaccharide at position 160, 187 or 131 as a parental virus and a mAb to an antigenic site different from that to which the mAb used for selection of the parental virus was directed as a selecting antibody, but there were no mutants with two new oligosaccharides. Glycosylation-site HA mutants containing one to three oligosaccharides at positions 160, 187 and 131 were also constructed and their intracellular transport and biological activities were analysed. The results showed that all of the mutant HAs were transported to the cell surface but exhibited a decrease in both receptor-binding and cell-fusing activities. Thus, influenza A/H2N2 virus may have failed to increase the number of oligosaccharides on the HA because, if this happens, the biological activities of the HA are reduced, decreasing the ability of the virus to replicate in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961269     DOI: 10.1099/0022-1317-83-5-1137

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  31 in total

1.  Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion.

Authors:  Vanessa R Melanson; Ronald M Iorio
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Adjuvant effects mediated by the carbohydrate recognition domain of Agrocybe aegerita lectin interacting with avian influenza H9N2 viral surface glycosylated proteins.

Authors:  Li-Bao Ma; Bao-Yang Xu; Min Huang; Lv-Hui Sun; Qing Yang; Yi-Jie Chen; Ya-Lin Yin; Qi-Gai He; Hui Sun
Journal:  J Zhejiang Univ Sci B       Date:  2017 Aug.       Impact factor: 3.066

3.  Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

Authors:  Juine-Ruey Chen; Yueh-Hsiang Yu; Yung-Chieh Tseng; Wan-Ling Chiang; Ming-Feng Chiang; Yi-An Ko; Yi-Kai Chiu; Hsiu-Hua Ma; Chung-Yi Wu; Jia-Tsrong Jan; Kuo-I Lin; Che Ma; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

4.  Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003.

Authors:  K M Butt; Gavin J D Smith; Honglin Chen; L J Zhang; Y H Connie Leung; K M Xu; Wilina Lim; Robert G Webster; K Y Yuen; J S Malik Peiris; Yi Guan
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.

Authors:  Suman R Das; Scott E Hensley; Alexandre David; Loren Schmidt; James S Gibbs; Pere Puigbò; William L Ince; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

6.  Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.

Authors:  Yasuhiro Abe; Emi Takashita; Kanetsu Sugawara; Yoko Matsuzaki; Yasushi Muraki; Seiji Hongo
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Akiko Maeda; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants.

Authors:  Nikolai V Kaverin; Irina A Rudneva; Natalia A Ilyushina; Aleksandr S Lipatov; Scott Krauss; Robert G Webster
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Innate immunity to influenza virus: implications for future therapy.

Authors:  Mitchell R White; Mona Doss; Patrick Boland; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  Expert Rev Clin Immunol       Date:  2008-07-01       Impact factor: 4.473

10.  Probing the spatial organization of measles virus fusion complexes.

Authors:  Tanja Paal; Melinda A Brindley; Courtney St Clair; Andrew Prussia; Dominika Gaus; Stefanie A Krumm; James P Snyder; Richard K Plemper
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.